What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?

Published:2020-10 Issue: Volume:143 Page:109886
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Nicolau Lucas A.D.,Magalhães Pedro J.C.,Vale Mariana L.

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação de Amparo à Pesquisa do Estado do Piauí

Publisher

Elsevier BV

Subject

General Medicine

Reference68 articles.

1. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor;Hoffmann;Cell,2020

2. Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin;Silva;Am J Physiol-Legacy Content,1949

3. Potentiation of bradykinin and eledoisin by BPF (bradykinin potentiating factor) from Bothrops jararaca venom;Ferreira;Experientia,1965

4. The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat;Ferreira;Br J Pharmacol Chemotherapy,1967

5. Niere und Kreislauf1;Tigerstedt;Skandinavisches Archiv Für Physiologie,1898

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human plasma kallikrein: roles in coagulation, fibrinolysis, inflammation pathways, and beyond;Frontiers in Physiology;2023-08-30

2. The role of the renin-angiotensin-aldosterone system in the development of cardiovascular complications in COVID-19;Pediatrician (St. Petersburg);2023-04-18

3. Three-Day Icatibant on Top of Standard Care in Patients With Coronavirus Disease 2019 Pneumonia: A Randomized, Open-Label, Phase 2, Proof-of-Concept Trial;Clinical Infectious Diseases;2023-01-04

4. Antiviral potential of diminazene aceturate against SARS-CoV-2 proteases using computational and in vitro approaches;Chemico-Biological Interactions;2022-11

5. SARS-CoV-2 Infection and C1-Esterase Inhibitor: Camouflage Pattern and New Perspective;Current Protein & Peptide Science;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3